Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Nonalcoholic Steatohepatitis Clinical Trials

3 recruiting trials for Nonalcoholic Steatohepatitis. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors

Recruiting Trials

RECRUITINGPhase 2NCT07481734

Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)

This randomized, double-blind, placebo-controlled Phase II study evaluates whether daily subcutaneous tesamorelin (a growth hormone-releasing hormone analog) reduces liver fat in...

Sponsor: Hudson BiotechEnrolling: 1201 location
RECRUITINGNCT02815891

A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across...

TARGET-NASH is a longitudinal observational cohort study of patients being managed for NASH and related conditions across the entire spectrum NAFLD in usual clinical practice....

Sponsor: Target PharmaSolutions, Inc.Enrolling: 1500020 locations
RECRUITINGPhase 2NCT04501406

Low-Dose Pioglitazone in Patients With NASH (AIM 2)

To determine the safety and efficacy of low-dose pioglitazone (15 mg per day) on liver histology in in patients with T2DM with biopsy-proven nonalcoholic steatohepatitis (NASH).

Sponsor: University of FloridaEnrolling: 1661 location